Brokers' group to ask Sebi to probe Ranbaxy trades

The president of a brokerage association is planning to formally request that market regulator Sebi investigate trading in Ranbaxy Laboratories Ltd shares in the days leading up to its acquisition by Sun Pharmaceutical Industries.

Ranbaxy shares surged 24 percent in the three trading sessions leading up to the announcement on Monday that Sun Pharmaceutical had agreed to buy Ranbaxy for $3.2 billion.

"Because there was such kind of price movement before the deal was announced, we have decided to check with the regulator," Naresh Tejwani, president of the Association of National Exchanges Members of India (ANMI) said on Wednesday.

"We will write to them by the end of the day to investigate into the matter."

A Ranbaxy spokesman declined to comment.

A spokesman for market regulator Securities and Exchange Board of India also declined to comment.

Sun Pharmaceutical did not immediately respond to requests for comment.


  • The govt should build on the feel good season to bolster its economic agenda

    There are two pieces of good news to ring in the festive season beginning this Dusshera.


Stay informed on our latest news!


Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs


Sachin Shridhar

Reordering the world order on cheap money

When you produce something, just about anything, capital is ...

Rajgopal Nidamboor

Of archetypes, not stereotypes

It is not that devising technologies, or progress, is a ...

Dharmendra Khandal

Use technology wisely to save earth's treasures

Wildlife biologists are certainly getting inspired by our armed forces’ ...


William D. Green

Chairman & CEO, Accenture